Actinium Pharmaceuticals reported $3.87M in Current Liabilities for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Actinium Pharmaceuticals ATNM:US $ 3.87M 291K
Amgen AMGN:US $ 14585M 1716M
Immunogen IMGN:US $ 120.32M 14.03M
Seattle Genetics SGEN:US $ 433.83M 44.22M
Spectrum Pharmaceuticals SPPI:US $ 56.7M 9.32M
Sunesis Pharmaceuticals SNSS:US $ 6.95M 0.69M